Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Trump Media and Technology Group Corp (DJT) vs BIO-TECHNE Corp (TECH) Price & Performance

Trump Media and Technology Group CorpTrade
BIO-TECHNE CorpTrade

Price performance (Past 24H)

Key statistics

Trump Media and Technology Group Corp vs BIO-TECHNE Corp — how do they compare? Trump Media and Technology Group Corp trades at $8.29 (market cap $2.28B), while BIO-TECHNE Corp trades at $72.46 (market cap $11.37B). The key difference: BIO-TECHNE Corp is far larger — about 5× Trump Media and Technology Group Corp's market cap, and BIO-TECHNE Corp pays a 0.44% dividend while Trump Media and Technology Group Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Trump Media and Technology Group Corp for 17 Days and BIO-TECHNE Corp for 63 Days on average.

DJTTECH
Market Cap
$2.28B$11.37B
Volume
4,132,6823,153,511
Sector
MediaHealth
52-Week High
$17.07$72.61
52-Week Low
$7.06$43.31
Typical Hold Time
17 Days63 Days
Enterprise Value
$2.35B$11.40B
Dividend Yield
—0.44%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Trump Media and Technology Group Corp

DJT trades at $8.22, down 4.97% today, with a bearish technical signal (18 sell vs 6 buy indicators). The company shows severe financial distress with negative net income margin of -28,860.41% and ROE of -78.93% despite recent merger progress with TAE Technologies. Cash flow trends indicate significant investing outflows of $2.3B in 2025, partially offset by financing activities.

The outlook remains highly speculative with substantial execution risks from the TAE merger and persistent profitability challenges. While the merger offers potential long-term upside in fusion energy, current fundamentals and technical indicators suggest continued pressure. Investors face high volatility amid negative earnings and cash flow trends.

BIO-TECHNE Corp

TECH trades at $72.53, near its 52-week high of $72.70, with a bullish technical signal and strong institutional interest. Recent earnings show mixed results, beating in Q2 2026 but missing in Q1. The company maintains solid profitability with a 65.77% gross margin, though net income declined to $73.40M in 2025. Shareholders approved an acquisition by Merck KGaA at $73.00 per share, a key near-term catalyst.

Outlook is positive due to the pending acquisition, but risks include execution challenges and valuation concerns with a high P/E of 62.53. Analyst consensus is divided with 46% buy ratings, suggesting cautious optimism. The stock offers limited upside to the acquisition price, making it suitable for event-driven investors.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DJT
100% Buy0% Sell
Avg holding period · 17 Days
TECH

No sentiment data available yet.

Top news

Latest headlines on both assets

About Trump Media and Technology Group Corp

Trump Media & Technology Group is a media firm rooted in social media and digital streaming. Its flagship product, Truth Social, provides a platform focused on free speech and open conversation.

Read more on DJT →

About BIO-TECHNE Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.

Read more on TECH →